• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GLUCAGON-LIKE PEPTIDE 1

PPARgamma and drugs for Alzheimer’s and Diabetes

September 17, 2018Alzheimer's, Diabetes, Metabolic Disorders, Nervous System Disorders, Vizit Graphs
PPARgamma ad common drugs and two major diseases, Alzheimer’s and Diabetes

“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

METFORMIN SOD1 CD4 RECEPTOR PSEUDOMONAS AERUGINOSA HELICOBACTER PYLORI CASP3 TH17 CELLS STAPHYLOCOCCUS AUREUS CTLA4 BREAST CANCER DOXORUBICIN ALZHEIMER'S DISEASE IFNG 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IL17A CELL PROLIFERATION AUTOPHAGY REMICADE CLOSTRIDIUM DIFFICILE IL6 STREPTOCOCCUS PNEUMONIAE TP53 APOPTOTIC PROCESS PARKINSON DISEASE TNF CELL DEATH IL23A ESCHERICHIA COLI ERBB-2 INSULIN IMMUNE RESPONSE INFLAMMATION ANGIOGENESIS NEURODEGENERATIVE DISORDERS RHEUMATOID ARTHRITIS CANDIDA ALBICANS PORPHYROMONAS GINGIVALIS AGING LISTERIA MONOCYTOGENES FOXP3 DIABETES MELLITUS CANCER CELL DIFFERENTIATION CELL DIVISION

© 2019 Biovista Vizit All Rights Reserved.